Insmed Net Change in Cash increased by 107.6% to $71.74M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 147.3%, from -$151.78M to $71.74M. Over 2 years (FY 2022 to FY 2024), Net Change in Cash shows a downward trend with a -54.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
A positive change indicates net cash generation, while a negative change indicates cash consumption for the period.
The total net increase or decrease in cash, cash equivalents, and restricted cash during the reporting period. It is the...
A fundamental liquidity metric used to compare cash management efficiency across all public companies.
net_change_in_cash| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $518.58M | -$81.77M | -$201.08M | -$99.63M | -$1.45M | $659.40M | -$105.13M | -$356.03M | -$125.77M | -$4.74M | $113.36M | $651.07M | -$785.35M | $93.58M | -$151.78M | $881.08M | -$949.56M | $71.74M |
| QoQ Change | — | -115.8% | -145.9% | +50.5% | +98.5% | >999% | -115.9% | -238.7% | +64.7% | +96.2% | >999% | +474.4% | -220.6% | +111.9% | -262.2% | +680.5% | -207.8% | +107.6% |
| YoY Change | — | — | — | -119.2% | +98.2% | — | +47.7% | -257.4% | <-999% | -100.7% | +207.8% | +282.9% | -524.4% | >999% | -233.9% | +35.3% | -20.9% | +147.3% |